Status
Conditions
Treatments
About
The aim of the registry is the assessment of the diagnosis and treatment of CTEPH (Chronic Thromboembolic Pulmonary Hypertension) in EMEA (Europe/Middle East/Africa) countries.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Female and male patients ≥ 18 years of age, diagnosed with CTEPH regardless of the current treatment
Availability of a signed informed consent
WHO Pulmonary Hypertension clinical classification Group IV (CTEPH):
Right heart catheterization (RHC) results that are in line with both of the following haemodynamic levels:
Confirmation of CTEPH diagnosis by one of the following as recommended by standard guidelines:
Exclusion criteria
231 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal